R. Abir et al., PRESERVATION OF FERTILITY IN WOMEN UNDERGOING CHEMOTHERAPY - CURRENT APPROACH AND FUTURE-PROSPECTS, Journal of assisted reproduction and genetics, 15(8), 1998, pp. 469-477
Purpose: Anticancer treatment causes ovarian failure. Methods: Some ho
rmones may have a protective effect on the ovary. Cryopreservation (fr
eezing) of oocytes has had very limited success, and therefore, curren
tly its use before chemotherapy is not a feasible option. However; cry
opreservation of embryos is possible. Another solution is oocyte donat
ion followed by in vitro fertilization (IVF). Results: Ovarian cortica
l slices containing primordial follicles have been cryopreserved succe
ssfully. To restore fertility, cryopreserved-thawed tissue taken from
cancer patients before therapy could be replanted after recovery. The
possible risk of malignancy restoration could be eliminated by obtaini
ng unilaminar follicles from cryopreserved-thawed tissue and growing t
hem in vitro, followed by routine IVF: Conclusions: Although women who
undergo chemotherapy face limited options for fertility preservation,
intensive studies in cryopreservation and in vitro maturation of foll
icles harbor hope for brighter prospects in the future.